1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Zhangzhou Pientzehuang Pharmaceutical., Ltd
  6. News
  7. Sector news
    600436   CNE000001F21

ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD

(600436)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Sector news Other Pharmaceuticals
11:41aEU health regulator backs using AstraZeneca COVID shot as booster
RE
07:53aPFIZER INC : Berenberg sticks Neutral
MD
07:27aROCHE HOLDINGS AG : Credit Suisse reiterates its Neutral rating
MD
05/18INSIDER SELL : Abbvie
MT
05/18INSIDER SELL : Abbvie
MT
05/18From storage to transport, hurdles to getting COVID vaccine to N.Koreans
RE
05/18China Junshi's potential COVID drug shows promise in small trial
RE
05/17BioNTech SE and Pfizer Inc. Announces the U.S. Food and Drug Administration Expands Eme..
CI
05/17DXC Technology Appoints Mike Salvino as Chairman, Succeeding Ian Read
MT
05/17Berkshire Hathaway Divests Wells Fargo Stake, Picks Up Citi Shares in Portfolio Reshuff..
MT
05/17Pfizer-BioNTech COVID-19 Vaccine Booster Approved for Children 5 to 11 Years Old in US
MT
05/17INSIDER SELL : Pfizer
MT
05/17Pfizer, BioNTech Receive US Approval for COVID-19 Jab Booster Dose for Children
MT
05/17Pfizer and BioNTech SE Granted U.S. Emergency Use Authorization for Booster Dose of The..
CI
05/17Pfizer Gets FDA Emergency Use Authorization for COVID-19 Vaccine as Booster Dose in Chi..
MT
05/17AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Add Recommendation
MT
05/17FDA Expands Authorization of Pfizer Covid Booster to Kids 5 to 11
DJ
05/17Citigroup Adjusts Price Target on Johnson & Johnson to $205 From $210, Reiterates Buy R..
MT
05/17PRESS RELEASE : Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech..
DJ
05/17PFIZER INC : Barclays remains Neutral
MD
05/16Mirati Therapeutics Appoints Laurie Stelzer CFO
MT
05/16Berkshire Hathaway Exited Bristol Myers and AbbVie Stakes in 1Q
DJ
05/16Eli Lilly Says FDA Approves Mounjaro Injection to Control Diabetes; Shares Rise
MT
05/16GLOBAL MARKETS LIVE : Pfizer, Tesla, Holcim, Novartis, Ford...
05/16AbbVie Receives Option to License Worldwide Rights to Cugene's CUG252 for Autoimmune, I..
MT
05/16TRANSCRIPT : Roche Holding AG - Special Call
CI
05/16Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European C..
CI
05/16INSIDER SELL : Pfizer
MT
05/15Pfizer, BioNTech Agree To Move Delivery Schedules For COVID-19 Vaccines In EU
MT
05/13FDA Approves Lilly's Mounjaro (Tirzepatide) Injection, the First and Only GIP and GLP-1..
CI
05/13FDA Approves Eli Lilly's Novel, Dual-Targeted Treatment for Type 2 Diabetes
MT
05/13Berenberg Bank Adjusts Eli Lilly's Price Target to $345 From $305, Maintains Buy Rating
MT
05/13N.Korea gets offers of aid to fight COVID as it lacks vaccines
RE
05/13ROCHE HOLDINGS AG : Reduced to Neutral by Jefferies
MD
05/12Roche believes cancer drug setback not a fatal blow to growth prospects
RE
05/12ROCHE HOLDINGS AG : Gets a Neutral rating from Morgan Stanley
MD
05/12ROCHE HOLDINGS AG : Deutsche Bank lowers his opinion and switches to Neutral
MD
05/12Roche Teams Up With Global Fund To Boost Diagnostic Systems In Low, Middle-income Natio..
MT
05/11Declaration of Voting Results by AbbVie Inc
CI
05/11Declaration of Voting Results by AbbVie Inc
CI
05/11Declaration of Voting Results by AbbVie Inc
CI
05/11Declaration of Voting Results by AbbVie Inc
CI
05/11TRANSCRIPT : Johnson & Johnson Presents at Bank of America 2022 Healthcare Conference, May..
CI
05/11New class of cancer drugs down, not out, after Roche trial setback - analysts
RE
05/11Pfizer's $11.6 billion Biohaven buy could spark more biotech deals
RE
05/11Pfizer's South Africa COVID-19 Jab Production Plans Faces Scaleback As Demand Thins Out
MT
05/11AbbVie Says Its Crohn's Disease Therapy Performed 'Significantly' Better Than Placebo i..
MT
05/11Roche, Electronic Health Solutions Team-Up on Healthcare Tech in Jordan
MT
05/11Deutsche Bank Lowers Price Target on Roche, Downgrades Recommendation to Hold From Buy
MT
05/11ROCHE HOLDINGS AG : Receives a Buy rating from Bernstein
MD
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD